APO Research
Talk to an analyst

APO RESEARCH · REPORT

Type 1 Diabetes (T1D)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Type 1 Diabetes (T1D) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchType 1 Diabetes (T1D) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 1 Diabetes (T1D) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Type 1 Diabetes (T1D) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 1 Diabetes (T1D) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 1 Diabetes (T1D) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Type 1 Diabetes (T1D) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Type 1 Diabetes (T1D) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Type 1 Diabetes (T1D) include Janssen, Sanofi, Sanofi, Novo Nordisk, Merck, Eli Lilly, Samsung Bioepis, Lexicon and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Type 1 Diabetes (T1D) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Type 1 Diabetes (T1D) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Type 1 Diabetes (T1D) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Type 1 Diabetes (T1D) market size, projected growth trends, production technologies, key applications, and end-use industries.

Type 1 Diabetes (T1D) Segment by Company

Janssen

Sanofi

Sanofi

Novo Nordisk

Merck

Eli Lilly

Samsung Bioepis

Lexicon

Bristol-Myers Squibb

Boehringer Ingelheim

Biocon

Astellas

Type 1 Diabetes (T1D) Segment by Type

Long Acting Insulin Analogs

Premix Insulin Analogs

Rapid Acting Insulin Analogs

Type 1 Diabetes (T1D) Segment by Application

Children

Adults

Type 1 Diabetes (T1D) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 1 Diabetes (T1D) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 1 Diabetes (T1D) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 1 Diabetes (T1D).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Type 1 Diabetes (T1D) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Type 1 Diabetes (T1D) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Type 1 Diabetes (T1D) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Type 1 Diabetes (T1D) Industry Trends Table 2. Type 1 Diabetes (T1D) Industry Drivers Table 3. Type 1 Diabetes (T1D) Industry Opportunities and Challenges Table 4. Type 1 Diabetes (T1D) Industry Restraints Table 5. Global Type 1 Diabetes (T1D) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Type 1 Diabetes (T1D) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Type 1 Diabetes (T1D) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers Table 9. Global Type 1 Diabetes (T1D) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Type 1 Diabetes (T1D) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Type 1 Diabetes (T1D) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Type 1 Diabetes (T1D) Manufacturers, Product Type & Application Table 13. Global Type 1 Diabetes (T1D) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Type 1 Diabetes (T1D) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Long Acting Insulin Analogs Table 17. Major Manufacturers of Premix Insulin Analogs Table 18. Major Manufacturers of Rapid Acting Insulin Analogs Table 19. Global Type 1 Diabetes (T1D) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 21. Global Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 22. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2021-2026) Table 23. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2027-2032) Table 24. Global Type 1 Diabetes (T1D) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (k units) Table 26. Global Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (k units) Table 27. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2021-2026) Table 28. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Children Table 30. Major Manufacturers of Adults Table 31. Global Type 1 Diabetes (T1D) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 33. Global Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 34. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2021-2026) Table 35. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2027-2032) Table 36. Global Type 1 Diabetes (T1D) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (k units) Table 38. Global Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (k units) Table 39. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2021-2026) Table 40. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2027-2032) Table 41. Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Type 1 Diabetes (T1D) Sales by Region (2021-2026) & (k units) Table 43. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2021-2026) Table 44. Global Type 1 Diabetes (T1D) Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Type 1 Diabetes (T1D) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 48. North America Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 49. Europe Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 51. Europe Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 58. Global Type 1 Diabetes (T1D) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Type 1 Diabetes (T1D) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Type 1 Diabetes (T1D) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2021-2026) Table 62. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2027-2032) Table 63. Janssen Company Information Table 64. Janssen Business Overview Table 65. Janssen Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Janssen Type 1 Diabetes (T1D) Product Portfolio Table 67. Janssen Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 72. Sanofi Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 77. Sanofi Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Merck Type 1 Diabetes (T1D) Product Portfolio Table 87. Merck Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eli Lilly Type 1 Diabetes (T1D) Product Portfolio Table 92. Eli Lilly Recent Development Table 93. Samsung Bioepis Company Information Table 94. Samsung Bioepis Business Overview Table 95. Samsung Bioepis Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio Table 97. Samsung Bioepis Recent Development Table 98. Lexicon Company Information Table 99. Lexicon Business Overview Table 100. Lexicon Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lexicon Type 1 Diabetes (T1D) Product Portfolio Table 102. Lexicon Recent Development Table 103. Bristol-Myers Squibb Company Information Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio Table 107. Bristol-Myers Squibb Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Biocon Company Information Table 114. Biocon Business Overview Table 115. Biocon Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Biocon Type 1 Diabetes (T1D) Product Portfolio Table 117. Biocon Recent Development Table 118. Astellas Company Information Table 119. Astellas Business Overview Table 120. Astellas Type 1 Diabetes (T1D) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Astellas Type 1 Diabetes (T1D) Product Portfolio Table 122. Astellas Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Type 1 Diabetes (T1D) Distributors List Table 126. Type 1 Diabetes (T1D) Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Type 1 Diabetes (T1D) Product Image Figure 2. Global Type 1 Diabetes (T1D) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 1 Diabetes (T1D) Market Size (2021-2032) & (US$ Million) Figure 4. Global Type 1 Diabetes (T1D) Sales (2021-2032) & (k units) Figure 5. Global Type 1 Diabetes (T1D) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Type 1 Diabetes (T1D) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Long Acting Insulin Analogs Image Figure 9. Premix Insulin Analogs Image Figure 10. Rapid Acting Insulin Analogs Image Figure 11. Global Type 1 Diabetes (T1D) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Type 1 Diabetes (T1D) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2021-2032) Figure 14. Global Type 1 Diabetes (T1D) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Type 1 Diabetes (T1D) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2021-2032) Figure 17. Children Image Figure 18. Adults Image Figure 19. Global Type 1 Diabetes (T1D) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Type 1 Diabetes (T1D) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2021-2032) Figure 22. Global Type 1 Diabetes (T1D) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Type 1 Diabetes (T1D) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2021-2032) Figure 25. North America Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2032) Figure 27. U.S. Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2032) Figure 32. Germany Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2032) Figure 39. China Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Type 1 Diabetes (T1D) Sales Market Share by Country (2021-2032) Figure 47. Brazil Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Type 1 Diabetes (T1D) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Type 1 Diabetes (T1D) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Type 1 Diabetes (T1D) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Figure 58. North America Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Type 1 Diabetes (T1D) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Type 1 Diabetes (T1D) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Insulin Analogs
  • Premix Insulin Analogs
  • Rapid Acting Insulin Analogs
Applications
  • Children
  • Adults
Companies covered
  • Janssen
  • Sanofi
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Samsung Bioepis
  • Lexicon
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Biocon
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Type 1 Diabetes (T1D) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Type 1 Diabetes (T1D) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Type 1 Diabetes (T1D) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Type 1 Diabetes (T1D) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Type 1 Diabetes (T1D) Market Dynamics
  1. 2.1 Type 1 Diabetes (T1D) Industry Trends
  2. 2.2 Type 1 Diabetes (T1D) Industry Drivers
  3. 2.3 Type 1 Diabetes (T1D) Industry Opportunities and Challenges
  4. 2.4 Type 1 Diabetes (T1D) Industry Restraints
3 Type 1 Diabetes (T1D) Market by Manufacturers
  1. 3.1 Global Type 1 Diabetes (T1D) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Type 1 Diabetes (T1D) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Type 1 Diabetes (T1D) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Type 1 Diabetes (T1D) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Type 1 Diabetes (T1D) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Type 1 Diabetes (T1D) Manufacturers, Product Type & Application
  7. 3.7 Global Type 1 Diabetes (T1D) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Type 1 Diabetes (T1D) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Type 1 Diabetes (T1D) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Type 1 Diabetes (T1D) Tier 1, Tier 2, and Tier 3
4 Type 1 Diabetes (T1D) Market by Type
  1. 4.1 Type 1 Diabetes (T1D) Type Introduction
  2. 4.1.1 Long Acting Insulin Analogs
  3. 4.1.2 Premix Insulin Analogs
  4. 4.1.3 Rapid Acting Insulin Analogs
  5. 4.2 Global Type 1 Diabetes (T1D) Sales by Type
  6. 4.2.1 Global Type 1 Diabetes (T1D) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Type 1 Diabetes (T1D) Sales by Type (2021-2032)
  8. 4.2.3 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Type 1 Diabetes (T1D) Revenue by Type
  10. 4.3.1 Global Type 1 Diabetes (T1D) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Type 1 Diabetes (T1D) Revenue by Type (2021-2032)
  12. 4.3.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2021-2032)
5 Type 1 Diabetes (T1D) Market by Application
  1. 5.1 Type 1 Diabetes (T1D) Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Type 1 Diabetes (T1D) Sales by Application
  5. 5.2.1 Global Type 1 Diabetes (T1D) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Type 1 Diabetes (T1D) Sales by Application (2021-2032)
  7. 5.2.3 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Type 1 Diabetes (T1D) Revenue by Application
  9. 5.3.1 Global Type 1 Diabetes (T1D) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Type 1 Diabetes (T1D) Revenue by Application (2021-2032)
  11. 5.3.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2021-2032)
6 Global Type 1 Diabetes (T1D) Sales by Region
  1. 6.1 Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Type 1 Diabetes (T1D) Sales by Region (2021-2032)
  3. 6.2.1 Global Type 1 Diabetes (T1D) Sales by Region (2021-2026)
  4. 6.2.2 Global Type 1 Diabetes (T1D) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Type 1 Diabetes (T1D) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Type 1 Diabetes (T1D) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Type 1 Diabetes (T1D) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Type 1 Diabetes (T1D) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Type 1 Diabetes (T1D) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Type 1 Diabetes (T1D) Revenue by Region
  1. 7.1 Global Type 1 Diabetes (T1D) Revenue by Region
  2. 7.1.1 Global Type 1 Diabetes (T1D) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Type 1 Diabetes (T1D) Revenue by Region (2021-2026)
  4. 7.1.3 Global Type 1 Diabetes (T1D) Revenue by Region (2027-2032)
  5. 7.1.4 Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Type 1 Diabetes (T1D) Revenue (2021-2032)
  8. 7.2.2 North America Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Type 1 Diabetes (T1D) Revenue (2021-2032)
  11. 7.3.2 Europe Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Type 1 Diabetes (T1D) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Type 1 Diabetes (T1D) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Type 1 Diabetes (T1D) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen
  2. 8.1.1 Janssen Company Information
  3. 8.1.2 Janssen Business Overview
  4. 8.1.3 Janssen Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Type 1 Diabetes (T1D) Product Portfolio
  6. 8.1.5 Janssen Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novo Nordisk
  20. 8.4.1 Novo Nordisk Company Information
  21. 8.4.2 Novo Nordisk Business Overview
  22. 8.4.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio
  24. 8.4.5 Novo Nordisk Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Type 1 Diabetes (T1D) Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Type 1 Diabetes (T1D) Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Samsung Bioepis
  38. 8.7.1 Samsung Bioepis Company Information
  39. 8.7.2 Samsung Bioepis Business Overview
  40. 8.7.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio
  42. 8.7.5 Samsung Bioepis Recent Developments
  43. 8.8 Lexicon
  44. 8.8.1 Lexicon Company Information
  45. 8.8.2 Lexicon Business Overview
  46. 8.8.3 Lexicon Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lexicon Type 1 Diabetes (T1D) Product Portfolio
  48. 8.8.5 Lexicon Recent Developments
  49. 8.9 Bristol-Myers Squibb
  50. 8.9.1 Bristol-Myers Squibb Company Information
  51. 8.9.2 Bristol-Myers Squibb Business Overview
  52. 8.9.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio
  54. 8.9.5 Bristol-Myers Squibb Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
  61. 8.11 Biocon
  62. 8.11.1 Biocon Company Information
  63. 8.11.2 Biocon Business Overview
  64. 8.11.3 Biocon Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biocon Type 1 Diabetes (T1D) Product Portfolio
  66. 8.11.5 Biocon Recent Developments
  67. 8.12 Astellas
  68. 8.12.1 Astellas Company Information
  69. 8.12.2 Astellas Business Overview
  70. 8.12.3 Astellas Type 1 Diabetes (T1D) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Astellas Type 1 Diabetes (T1D) Product Portfolio
  72. 8.12.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Type 1 Diabetes (T1D) Value Chain Analysis
  2. 9.1.1 Type 1 Diabetes (T1D) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Type 1 Diabetes (T1D) Production Mode & Process
  6. 9.2 Type 1 Diabetes (T1D) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Type 1 Diabetes (T1D) Distributors
  9. 9.2.3 Type 1 Diabetes (T1D) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst